Bipolar Disorder (2018) |
1.12 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
AC103965.1 ADD3 ITIH4-AS1 |
Bipolar Disorder or Schizophrenia |
1.05 |
10 |
5 |
11.1 |
-0.02 |
9.5e-01 |
AC074117.10 AC103965.1 DOC2A GMIP ITIH4-AS1 L3MBTL2 LMAN2L MRPS21 RP11-231C14.4 STAT6 |
Depressed Affect (Nagel 2018) |
1.18 |
9 |
4 |
8.9 |
-0.60 |
8.7e-02 |
AMT ARL17B KCTD10 MDH2 PLCL2 PLEKHM1 PPTC7 RP5-1115A15.1 THRA |
Intelligence (Savage-Jansen 2018) |
0.88 |
8 |
4 |
8.9 |
-0.14 |
7.4e-01 |
AMT MAST3 PLA2G15 PLEKHM1 RAB5B REST TCTA UBA7 |
Neuroticism (Nagel 2018) |
1.15 |
10 |
7 |
15.6 |
-0.38 |
2.5e-01 |
AHSA2 ARL17B EP300 KCTD10 L3MBTL2 PEX13 PLCL2 PLEKHM1 RP5-1115A15.1 THRA |
Schizophrenia (2018) |
1.05 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
C12orf24 GMIP STAT6 |
Schizophrenia vs Biploar Disorder |
1.20 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
PPTC7 VPS29 |
Worry (Nagel 2018) |
1.09 |
8 |
4 |
8.9 |
0.02 |
9.6e-01 |
AHSA2 ARL17B DOC2A EP300 KCTD10 L3MBTL2 PLEKHM1 PPP4C |
Alzheimer’s Disease (in mother) |
1.41 |
3 |
3 |
6.7 |
0.00 |
1.0e+00 |
APOC1 APOC4 TOMM40 |
Alzheimer’s Disease (in father) |
1.13 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
APOC1 APOC4 TOMM40 |
Alzheimer’s Disease (including proxy) |
1.93 |
7 |
5 |
11.1 |
-0.26 |
5.7e-01 |
APOC1 APOC4 B4GALT3 CKM GIGYF1 INPP5D TOMM40 |
Crohns Disease (2017) |
2.17 |
35 |
26 |
57.8 |
0.01 |
9.7e-01 |
ABO ADO CAMSAP2 CCDC116 CCDC88B CENPO CUL2 EGR2 FADS1 GMEB2 GPR35 GSDMB HINT1 ICOSLG IGHEP2 IL18R1 JAK2 KIAA1109 KIF3A LRRC32 LYRM7 NCF4 NDFIP1 PEX13 PPP1R1B PPP5C PTPN2 RHOA-IT1 SEC16A SLC22A5 SMAD3 SP140 TNFSF15 TNFSF8 ZFP36L2 |
Irritable Bowel Disease (IBD) |
2.38 |
41 |
29 |
64.4 |
0.13 |
3.5e-01 |
AC016747.3 ADO AHSA2 C16orf75 CAMSAP2 CCDC116 CENPO CTSS CUL2 DAP DR1 EGR2 GMEB2 GOLPH3L GPR35 GSDMB HHEX ICOSLG IGHEP2 IL18R1 IL1R2 JAK2 KIAA1109 KIF11 LRRC32 LYRM7 NDFIP1 ORMDL3 PEX13 POLR2E PPP1R1B PPP5C PTPN2 RGS14 RMI2 SEC16A SLC22A5 SMAD3 TNFRSF14 TNFSF15 ZFP36L2 |
Ulcerative Colitis (UC) |
1.98 |
22 |
14 |
31.1 |
0.16 |
4.2e-01 |
AC016747.3 AHSA2 AMT CAMSAP2 GNA12 GPR35 GSDMB IGHEP2 IRF5 JAK2 PDCD1LG2 PEX13 PPP1R1B PTPN2 RGS14 RP11-493E12.2 SEC16A THRA TNFRSF14 TNFSF15 ZFP36L2 ZFP90 |
Reaction Time |
1.08 |
4 |
2 |
4.4 |
0.90 |
1.0e-01 |
MAPKAPK5-AS1 RMI1 RNF185 SH2B3 |
Verbal and Numeric Reasoning (VNR) |
0.95 |
4 |
1 |
2.2 |
0.00 |
1.0e+00 |
PLEKHM1 RAB5B TCTA UBA7 |
Breast Cancer |
0.97 |
12 |
5 |
11.1 |
-0.33 |
2.7e-01 |
AKAP9 CENPO CPEB4 CTC-228N24.3 EFEMP2 FAM114A1 KRIT1 PLEKHM1 PVT1 RIN3 SIDT2 SIK2 |
Ovarian Cancer |
1.00 |
4 |
1 |
2.2 |
0.77 |
2.3e-01 |
ABO ARL17B PLEKHM1 PNPO |
Prostate Cancer |
1.44 |
6 |
3 |
6.7 |
0.55 |
2.5e-01 |
GEMIN4 IDI1 PVT1 RPN1 RUVBL1 VAMP8 |
Age at First Birth |
1.10 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
TCTA UBA7 |
Body Mass Index (BMI) (2010) |
1.22 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
TRIM73 |
Coronary Artery Disease (CAD) |
1.46 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
NBEAL1 TOM1L2 UBE2Z |
Crohns Disease (2012) |
1.91 |
19 |
13 |
28.9 |
-0.01 |
9.6e-01 |
ADO CCDC116 CUL2 EGR2 FADS1 GMEB2 HINT1 IGHEP2 IL18R1 INSL6 LRRC32 NDFIP1 PTPN2 RHOA-IT1 SEC16A SLC22A5 SMAD3 TNFSF15 TNFSF8 |
Fasting Glucose |
1.21 |
4 |
3 |
6.7 |
0.74 |
2.6e-01 |
C11orf10 FADS1 NOSTRIN QPCTL |
HDL Cholesterol |
1.74 |
15 |
13 |
28.9 |
0.39 |
1.3e-01 |
C11orf10 CCDC116 FADS1 FADS2 FPR3 GSDMB KCTD10 LPL LRRC29 ORMDL3 PLA2G15 PPP1R1B PSMC3 RP11-138A9.1 ZNF259 |
LDL Cholesterol |
1.64 |
10 |
9 |
20.0 |
0.04 |
9.0e-01 |
ABO APOC1 C11orf10 CARM1 FADS1 FADS2 MYRF SH2B3 TOMM40 ZNF259 |
Lupus |
1.44 |
6 |
3 |
6.7 |
-0.20 |
7.0e-01 |
C17orf37 CCDC116 DEXI GSDMB IRF5 ORMDL3 |
Neuroticism (2016) |
1.05 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
PLEKHM1 |
Primary Biliary Cirrhosis |
1.69 |
14 |
8 |
17.8 |
0.31 |
2.4e-01 |
CARM1 CCDC88B DEXI FCRL3 GSDMB IL7R IRF5 LTBR ORMDL3 PLCL2 PLEKHM1 PPP1R1B RMI2 SH2B3 |
Rheumatoid Arthritis |
1.52 |
5 |
2 |
4.4 |
0.56 |
2.5e-01 |
FADS2 FAM208B IRF5 PTPN2 SH2B3 |
Schizophrenia (2014) |
1.06 |
6 |
2 |
4.4 |
0.61 |
2.0e-01 |
C12orf24 GMIP ITIH4-AS1 RP11-231C14.4 RP5-1115A15.1 TOM1L2 |
Triglycerides |
2.11 |
9 |
9 |
20.0 |
-0.84 |
2.4e-03 |
AC074117.10 APOC1 APOC4 C11orf10 FADS1 FADS2 LPL SIDT2 ZNF259 |
Type 2 Diabetes (T2D) (2012) |
1.38 |
4 |
4 |
8.9 |
-0.66 |
7.7e-02 |
EIF2S2P3 HHEX JAZF1 KIF11 |
Ulcerative Colitis |
1.80 |
10 |
2 |
4.4 |
0.34 |
3.3e-01 |
CAMSAP2 CUL2 GPR35 GSDMB IGHEP2 IRF5 JAK2 PPP1R1B TNFRSF14 ZFP90 |
Blood Platelet Count |
2.18 |
184 |
148 |
328.9 |
0.31 |
5.0e-06 |
ABCC5 ABO AC002310.12 AC006547.14 AC010883.5 AC021860.1 AC074117.10 AC074212.6 AC103965.1 AC114730.11 ADAM1A ADD3 ADO ANAPC1 ANKRD9 APOC1 ARNT ATM ATP5A1 BANF1 BAX BRD3 C11orf10 C12orf52 C16orf93 C21orf96 C3orf34 CCDC116 CCDC18 CD164 CD226 CD33 CDC7 CDIP1 CEBPZ CEP19 CEP85 CKM CLIC4 CNN2 CTSS CUX2 CYCSP34 DCUN1D3 DMWD DOC2A DR1 DSTN EFEMP2 EOMES ERMP1 FADS1 FADS2 FAM133B FAM46B FBXO6 FCHO2 FLJ13197 FOXO1 FRAT2 GATAD1 GFI1B GIGYF1 GMEB2 GMIP GNA12 GNPDA1 GOLPH3L GPN3 GPR35 GPX4 GRPEL1 GSDMB HBS1L HIP1 HLX IGHEP2 IRF5 JAK2 KAT5 KIAA0831 KIAA1875 KIF3A KRIT1 LACTB LBX2-AS1 LOC90246 LRRC37A16P LTBR MAP3K11 MARCH5 MAX MDH2 MED24 MFN2 MIIP MKRN2 MRPS21 MYB MYRF NBEAL2 NDFIP1 NFE2 NUCB2 NUDT3 OAS1 OAS3 PACSIN1 PAK2 PARP12 PCNXL3 PDE7A PEX7 PGC PHC2 PHF11 PIEZO1 PIK3C2B PLGRKT PLOD1 POLR2E POR PPP1CC PPP1R1B PPP4C PPTC7 PRTFDC1 PSMB7 PSMC3 PTEN QPCTL RAVER2 RCL1 REST RIN3 RLN2 RMI1 RMI2 RNASEH2C RNF166 RNF215 RP11-158M2.3 RP11-493E12.2 RP11-617D20.1 RP11-723O4.2 RP11-981P6.1 RPA2 RPH3A RPN1 RUVBL1 SBNO1 SENP7 SH2B3 SIK2 SIRT2 SIX5 SLC11A2 SLC22A18AS SLC22A5 SPPL3 STXBP6 SUGT1L1 SUPT4H1 SURF6 TBC1D4 TCTN1 TEAD3 THAP9-AS1 TIMP4 TNFRSF10B TNFRSF1A TOMM40 TRAPPC1 TRIM8 TRMT61A TSEN2 UBE2Z USP15 VLDLR VPS29 ZFP36L2 ZFP90 ZNF259 ZNF500 |
Blood Red Count |
1.79 |
122 |
104 |
231.1 |
0.33 |
6.1e-05 |
ABCC5 ABO AC010883.5 AC021860.1 AC074117.10 AC084018.1 ACBD4 ADAM1A AMT ANAPC1 ARL17B ATM ATP6V0D1 BACH2 BRD3 C11orf10 C11orf21 C12orf24 C16orf93 CACFD1 CCDC88B CD164 CKM CLIC4 CNN2 COLCA2 CPEB4 CTD-2020K17.4 CUX2 CYCSP34 DAP DOC2A DR1 EIF2S2P3 FADS1 FADS2 FAM114A1 FAM133B FLJ13197 FOXA1 FOXO1 FUCA1 FXR2 GBGT1 GFI1B GPN3 GSDMB GUCA1A HBS1L HHEX ID3 IGHEP2 JAK2 KIF11 KIF17 KLHL5 KRIT1 LHFPL5 LOC595101 MAP2K2 MAPKAPK5-AS1 MAX MCM4 MYB MYNN MYRF NDFIP1 NFE2 ORMDL3 PDE7A PIEZO1 PLEKHM1 PNPO POLI PPARG PPP1R1B PPP4C PPP5C PPTC7 PTPN1 PTPN2 RAD54L RAD9B RCL1 REXO4 RGS14 RHOA-IT1 RP11-158M2.3 RP11-231C14.4 RP11-45P15.4 RP11-617D20.1 RPLP0P2 SEPT2 SESN1 SH2B3 SPIDR SRPK1 SUGT1L1 SURF6 SYMPK TBX6 TCTA THAP9-AS1 TIMP4 TMEM116 TMEM150C TOM1L2 TP53INP1 TRAPPC1 TRERF1 TRIM8 TRMT112 TRMT61A TRPC1 TSEN2 TSPAN3 TSPY26P UBA7 UBE2E3 VPS29 YPEL3 ZFP90 |
Blood White Count |
3.89 |
191 |
154 |
342.2 |
0.53 |
9.3e-19 |
ABCC5 ABO AC006547.14 AC010883.5 AC012146.7 AC016747.3 AC084018.1 ACAD9 ADAM1A ADD3 ADRB2 AHI1 AHSA2 AK3P3 AKAP11 ALDH2 ALOX15 AP000350.4 APBB1IP APOC1 ARNT ARRB2 ATM ATP5A1 ATP6V0D1 AUH B4GALT3 BACH2 BAX BID C11orf10 C11orf21 C12orf52 C14orf174 C16orf93 C17orf107 C17orf37 C19orf44 C1orf200 C3orf34 C5orf34 C6orf164 C7orf40 CARM1 CCDC116 CCDC13 CCDC18 CCDC9 CD164 CD226 CD33 CDIP1 CDK6 CENPO CEP19 CHD7 CHERP CKM CUX2 CXCL12 CYP8B1 DEF6 DEXI DOC2A EFEMP2 EGR2 ENTPD2 EOMES EPS15L1 FADS1 FADS2 FAM133B FAM84B FBXO38 FRAT2 GATAD1 GMEB2 GNA12 GNPDA1 GPR87 GSDMB GSK3B HBS1L HIGD1A HLTF IFI35 IFITM2 IKZF2 IL17RA IL1R2 KIAA0831 KIF3A KRIT1 LAPTM5 LEPR LOC595101 LOC90246 MAPKAPK5-AS1 MAX MED11 MED24 MIF MKRN2 MPP2 MRPS21 MYRF NDFIP1 NFKBIA NLRC5 NOB1 NOSTRIN OAS1 OIP5-AS1 ORMDL3 PACSIN1 PAK2 PARP12 PELP1 PEX13 PEX7 PHF11 PIGX PISD PLA2R1 POLI POLR2E POM121L9P PPP1R1B PPTC7 PRPH2 PRTFDC1 PSMA6 PSMB7 PSMC3 PVT1 RAB4B RAB7A RBBP8 REST RGS14 RIN3 RMI1 RNASEH2C RNF14 RNF185 RP11-105N14.1 RP11-138A9.1 RP11-45P15.4 RP11-493E12.2 RP11-617D20.1 RP11-876N24.4 RP5-1115A15.1 RPA2 RPLP0P2 RPN1 SBNO1 SEC16A SH2B3 SIGLEC14 SLC11A2 SLC22A5 SPPL3 SPRED2 STXBP6 SURF6 TBX6 TCEA3 TCTA TCTN1 TFPI THAP9-AS1 THRA TMEM116 TMEM150C TNFRSF10B TNFRSF1A TOM1L2 TRERF1 TSGA10IP TSPAN3 UBA7 UBE2F VLDLR VPS29 WAC-AS1 WBP2 ZNF574 ZNF662 ZNF69 ZNF786 ZRANB1 |
Heel T-Score |
1.13 |
87 |
67 |
148.9 |
0.16 |
1.2e-01 |
ABO AKAP11 AKAP9 AMT APLNR ARHGEF19-AS1 ARL17B ATP6V0D1 BTG1 C11orf10 C16orf93 CAMSAP2 CCDC116 CCDC88B CCNO CEBPZ CIAO1 CPEB4 CRTC3 CTC-228N24.3 CTSS DEF6 DNAH7 EP300 ERMP1 FADS1 FADS2 FAM133B FCHO2 FGF11 FPR3 GATAD1 GNA12 GOLPH3L H6PD HLX HSPA4 ID3 IFI35 IQCH IRF5 KAT5 KRIT1 L3MBTL2 LCLAT1 LOC595101 LRRC29 MAP2K2 MAP3K11 MRPS21 NAALADL1 P4HTM PCNXL3 PEX1 PLEKHM1 POLR2E PRKD2 PSMA6 PSMB7 RAB5B REST RHOA-IT1 RMI1 RNASEH2C RNF185 RP11-231C14.4 RP11-45P15.4 RP11-85K15.2 RP4-800G7.2 RP5-1115A15.1 RPN1 SBNO1 SENP7 SLC11A2 SLC25A17 STOX1 TBX6 TCTA TFPI TRMT61A TRPC1 UBA7 UBE2E3 UQCRQ USP3 ZBTB11-AS1 ZFP36L2 |
BMI |
1.23 |
64 |
48 |
106.7 |
-0.10 |
4.3e-01 |
AC006547.14 ACTR1B ADAM10 C12orf24 C16orf93 C17orf107 C17orf58 CENPO CIRH1A CKM CPEB4 DOC2A EFEMP2 GPN3 HHEX HINT1 HSD3B7 IQCH ITIH4-AS1 JAZF1 LIN7C LINC00674 LOC595101 MAP2K2 MAP2K5 MAST3 MDH2 MED24 NOB1 NUDT3 OAS3 PACSIN1 PHC2 PNPO PPP4C PPTC7 PSMB7 PTK2B RAB5B RAD9B RP11-231C14.4 RP11-981P6.1 RPH3A RPN1 RSBN1L-AS1 SIDT2 SMAD3 TBX6 TCTA TEAD3 TFPI THRA TNFRSF14 TNIP2 TRIM73 TRIM8 TRMT61A TSPY26P UBA7 UBE2Z USP3 VPS29 WBP2 ZNHIT3 |
Height |
1.21 |
170 |
145 |
322.2 |
-0.13 |
6.9e-02 |
AC010883.5 AC021860.1 AC103965.1 ACBD4 ACTR1B ADO AHSA2 AK3P3 AKAP9 ALOXE3 AMT APOC1 APOC4 ARHGEF19-AS1 ARL17B ATP6V0D1 ATP9A BANF1 BRD3 C11orf10 C14orf39 C17orf58 C6orf81 CARM1 CCDC116 CCDC18 CCDC9 CD164 CENPO CEP85 COG6 CRTAP CTC-228N24.3 CTD-2020K17.4 CUX2 DCAF4 DEF6 DESI1 DGUOK-AS1 DLEU1 DMWD DOC2A DR1 DSTN EBPL EFCAB13 EGR2 EXOC2 FADS1 FADS2 FAM114A1 FAM133B FGF11 FLJ13197 FXR2 GATAD1 GIGYF1 GMIP GNA12 GRPEL1 HEMK1 HINT1 HIVEP3 IFI35 IL18RAP IL1R2 IQCH IRF5 ITIH4-AS1 JAZF1 KCNJ2 KIF17 KIF3A KRIT1 LBX2-AS1 LINC00674 LMAN2L LPL LRRC37A16P LYRM7 MAP2K2 MAP3K11 MARCH5 MAX MED24 MKRN2 MRPS21 NFKBIA NOB1 NOSTRIN NUCB2 NUDT3 OIP5-AS1 P4HTM PACSIN1 PAPD7 PARP12 PCNXL3 PEX1 PGC PHC2 PIAS1 PIEZO1 PLEKHM1 POLR2E PPARA PPP4C PPTC7 PRTFDC1 PSMC3 PTEN PUS10 RAB43 RAB4B RAD54L2 RBBP8 RBCK1 REST RGS14 RHOA-IT1 RMI1 RMND1 RNASEH2C RP11-231C14.4 RP11-517P14.2 RP11-617D20.1 RP5-1085F17.3 RP5-1115A15.1 RSBN1L-AS1 SBNO1 SEC16A SEMA3B-AS1 SEPT2 SESN1 SH2B3 SIGLEC5 SIX5 SLC11A2 SLC13A4 SLC22A5 SLC25A17 SPPL3 SPRED2 STAT6 STOX1 SUGT1L1 TBX6 TCTA TEAD3 THRA TLR6 TPSB2 TRAPPC1 TRMT61A TRPC1 TSEN2 TSGA10IP TSPAN3 UBE2Z UPF3A USP3 WAC-AS1 ZNF414 ZNF425 ZNF500 ZNF568 ZNF574 ZNF652 ZNF786 ZRANB1 |
Waist Hip Ratio (WHR) |
1.28 |
43 |
31 |
68.9 |
0.26 |
8.5e-02 |
ADAM10 AMT APOC1 ATP6V0D1 AUH CDIP1 CETN4P CPEB4 CTC-228N24.3 DMWD EIF2S2P3 IFI35 IFITM2 IQCH JAZF1 KAT5 KCNJ2 LRRC25 MAP3K11 MAST3 MKRN2 P4HTM PGC PISD PLEKHM1 PSMC3 RHOA-IT1 RNF185 RNF215 RP11-138A9.1 RSBN1L-AS1 SBNO1 SIX5 TCEA3 TCTA TFPI TOM1L2 TRMT112 TSEN2 TSGA10IP UQCRQ USP3 ZFP90 |
Systolic Blood Pressure |
1.34 |
76 |
49 |
108.9 |
0.31 |
4.3e-03 |
ABCC5 AC006547.14 AC010883.5 AC074212.6 ACBD4 ADAM1A ADO ADRB2 ARL17B C17orf58 CENPO CLDN7 CLIC4 CPEB4 CSTA CTC-228N24.3 CTD-2020K17.4 CUL2 DCUN1D3 DEF6 DMWD FAM133B FAM46B FXR2 GATAD1 GIMAP7 GPN3 HHEX ITIH4-AS1 KAT5 KRIT1 LIN7C LRRC37A16P MAP3K11 MAPKAPK5-AS1 MED19 MYNN NAT15 NDST2 NFKBIA NUCB2 OIP5-AS1 PEX1 PGC PLEKHM1 PPTC7 PSMB7 PSMC3 RIN3 RP11-138A9.1 RP11-158M2.3 RP11-298I3.1 RP11-981P6.1 RP5-1115A15.1 SENP7 SH2B3 SIK2 SIX5 SLC13A4 SMAD3 SMC4 SPRY4 TEAD3 THAP9-AS1 TMEM116 TOM1L2 TP53INP1 TRIM73 TRIM8 TRMT112 UBE2E3 UBE2Z UPF3A VPS29 WBP2 ZNF652 |
Smoking Status |
1.09 |
13 |
6 |
13.3 |
0.03 |
9.2e-01 |
AMT ARL17B CCDC88B DESI1 IQCH LIN7C P4HTM PDE7A PHC2 RAB5B RP5-1115A15.1 SEMA3B-AS1 ZNF652 |
Allergy or Eczema |
4.18 |
88 |
62 |
137.8 |
0.87 |
4.2e-35 |
ABO AC016747.3 AC093642.3 AC114730.7 AHI1 ATP9A B4GALT3 BACH2 CAMK4 CARD11 CCDC116 CD200R1 CD247 CEP19 CLEC16A CLIC4 D2HGDH DEXI EFEMP2 EP300 FAM114A1 FOXO1 GLDC GNPDA1 GPR182 GSDMB IGHEP2 IL18RAP IL1R2 IL1RL1 IL2RA IL4R IL7R JAK2 JAZF1 JMJD5 KIAA1109 KIAA1432 KIF3A L3MBTL2 LCLAT1 LRRC32 MAP3K11 MED24 NDFIP1 NRROS OIP5-AS1 ORMDL3 PACSIN1 PCNXL3 PEX13 PIGX PLGRKT POLI PPP1R1B PRKCQ PSMB7 RAB5B RGS14 RNASEH2C RP11-396B14.2 RP11-876N24.4 RP5-1115A15.1 SBNO1 SESN1 SIK2 SLC25A46 SLC9A2 SMAD3 SMAD4 SMARCE1 SPATA5 SPPL3 STAT6 SUGT1L1 THRA TLR6 TMEM201 TNFRSF14 TOM1L2 TSGA10IP TSLP UBAC2 WDR36 ZFP90 ZNF425 ZNF652 ZNHIT3 |
Cardiovascular Disease |
1.31 |
36 |
21 |
46.7 |
0.42 |
1.1e-02 |
AC006547.14 AC010883.5 ACTR1B ADO ADRB2 CARM1 CPEB4 FAM46B GATAD1 HSD3B7 LPL MAPKAPK5-AS1 NAT15 NFKBIA NUCB2 OIP5-AS1 PEX1 PNPO PSMC3 RP11-138A9.1 RP11-981P6.1 RP5-1115A15.1 SH2B3 SIK2 SMARCE1 SPRY4 TMEM116 TOMM40 TP53INP1 TRMT61A TSPY26P UBE2Z UPF3A WBP2 ZNF259 ZNF652 |
Hypothyroidism (self reported) |
2.23 |
46 |
26 |
57.8 |
0.47 |
5.8e-04 |
AC114730.7 ADAM1A AKAP11 ALDH2 ANKRD36 ATP6V0D1 BACH2 C11orf10 C12orf52 CCDC88B CD226 CD247 CHD7 CUX2 EFCAB13 EPS15L1 FADS1 FADS2 FAM208B FCHO2 FCRL3 GIGYF1 IFITM2 IL7R IRF5 LRRC25 MAPKAPK5-AS1 MYNN P4HTM PSMB7 PTPN2 PVT1 RAB5B RASGRP1 RAVER2 RP11-617D20.1 RP5-1115A15.1 SEPT2 SESN1 SH2B3 SIDT2 SSTR3 TCTN1 TMEM131 UBAC2 VPS29 |
Respiratory disease |
4.33 |
68 |
54 |
120.0 |
0.84 |
5.9e-25 |
AC074212.6 AC114730.11 AC114730.7 AHI1 BACH2 C11orf10 CBLC CD247 CLEC16A CTD-3203P2.1 D2HGDH DEF6 DEXI DMWD EIF2S2P3 FADS1 FADS2 FAM114A1 FOXO1 GLDC GMEB2 GNPDA1 GPR182 GSDMB HHEX IL18RAP IL1R2 IL1RL1 IL4R IL7R IQCH JMJD5 KIAA1109 KIAA1432 KIF11 KIF3A LRRC32 MARCH5 MED24 NBEAL1 NCF4 NDFIP1 NRROS OIP5-AS1 ORMDL3 POLI PPP1R1B PRKCQ RAB5B RGS14 RP11-396B14.2 RP11-876N24.4 RP5-1115A15.1 SIX5 SLC22A5 SLC25A46 SLC9A2 SMAD3 SPATA5 SPPL3 STAT6 TBX6 THRA TSLP UBA7 UBAC2 WDR36 ZNF652 |
Type 2 Diabetes (T2D) (2018) |
1.43 |
9 |
6 |
13.3 |
-0.10 |
7.4e-01 |
EIF2S2P3 HHEX JAZF1 KIF11 NOB1 RP11-138A9.1 TCTA UBA7 ZFP36L2 |
Lung FEV1/FVC ratio |
1.57 |
73 |
51 |
113.3 |
-0.19 |
8.6e-02 |
AC016747.3 AC074212.6 AC103965.1 ADD3 AHSA2 ATP6V0D1 BACH2 C16orf93 C17orf58 C20orf112 CCDC9 CDIP1 CENPO COG6 CPEB4 CTC-228N24.3 CTD-2007H13.3 D2HGDH DEF6 DMWD EBPL EHD4 EXOC2 FBXO38 FOXO1 GLDC GNA12 GNPDA1 IL1R2 IL1RL1 IL7R KIAA1211L L3MBTL2 LINC00674 LOC595101 LRRC25 LRRC29 LRRC37A16P LTBR NDST2 NFKBIA PEX13 PMM1 QPCTL RAB4B RAB5B RAB7A REST RGS14 RP11-298I3.1 RP11-396B14.2 RP11-493E12.2 RPN1 RUVBL1 SEPT2 SESN1 SIX5 SLC22A18AS SLC22A5 SLC9A2 SMAD3 STAT6 SYMPK TBX6 TCEA3 TEPP THRA TIGD2 TOM1L2 TSPAN3 TSPY26P ZFP36L2 ZNF652 |
Lung FVC |
1.13 |
40 |
27 |
60.0 |
0.17 |
2.7e-01 |
ARHGEF19-AS1 ARL17B ARNT C5orf34 C6orf81 CALM3 CTC-228N24.3 CTSS FGF11 FOXA1 FXR2 GMEB2 GOLPH3L GSDMB HEMK1 HLX IQCH JAZF1 LIN7C LRRC25 LRRC37A16P MRPS21 NAT15 NOB1 PACS1 PIEZO1 PLEKHM1 PPP1R1B RAB5B RIN3 RP11-493E12.2 SEC16A SKAP2 SLC22A5 SPPL3 SRPK1 TEAD3 TSEN2 UQCRQ VMAC |
Neuroticism |
1.12 |
12 |
5 |
11.1 |
-0.37 |
2.2e-01 |
AHSA2 ARL17B EP300 IQCH KCTD10 L3MBTL2 PLCL2 PLEKHM1 RNF166 RP5-1115A15.1 TCEA3 THRA |
Chronotype (morning person) |
1.08 |
7 |
3 |
6.7 |
0.25 |
5.9e-01 |
DESI1 GOLPH3L MAPKAPK5-AS1 PSMB7 RMI1 SEC16A ZNF574 |
Hair Pigment |
0.33 |
32 |
26 |
57.8 |
0.01 |
9.7e-01 |
AC006547.14 ADD3 BANF1 C11orf10 C14orf39 C20orf112 CDIP1 CUL2 DUSP6 EOMES EXOC2 FADS2 GIGYF1 GMEB2 JAZF1 KAT5 KIAA1432 L3MBTL2 MAPKAPK5-AS1 PIEZO1 PNPO RANBP6 REST RIN3 RNF166 RP11-299J3.8 RP11-981P6.1 RP5-1085F17.3 SBNO1 SH2B3 TRMT61A TSPY26P |
Tanning |
0.31 |
13 |
9 |
20.0 |
0.27 |
3.4e-01 |
ARNT CERS2 CTSC CTSS EXOC2 GOLPH3L JAZF1 PGC PIEZO1 RNF166 SH2B3 ST3GAL6 TSPY26P |
Hand grip strength (left) |
1.05 |
12 |
6 |
13.3 |
-0.63 |
2.7e-02 |
ARL17B C17orf58 CENPO DEF6 DOC2A LRRC37A16P NOB1 PHC2 PLEKHM1 PPP4C SLC22A5 TBX6 |
Number of treatments/medications taken |
1.33 |
7 |
3 |
6.7 |
0.88 |
3.9e-03 |
C17orf58 LINC00674 RP11-617D20.1 SH2B3 TCTA UBA7 ZNF652 |
Sensitivity / hurt feelings |
1.00 |
3 |
2 |
4.4 |
0.00 |
1.0e+00 |
ARL17B KCTD10 PLEKHM1 |
Frequency of depressed mood in last 2 weeks |
1.03 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RP5-1115A15.1 |
Relative age of first facial hair |
1.00 |
5 |
3 |
6.7 |
-0.33 |
5.8e-01 |
ARL17B PLEKHM1 RAD54L2 SPPL3 USP3 |
Ever used hormone-replacement therapy (HRT) |
1.12 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
PSMB7 |
Systolic blood pressure, automated reading |
1.24 |
32 |
14 |
31.1 |
0.33 |
6.3e-02 |
AC006547.14 AC074212.6 ACBD4 ADRB2 ARL17B CPEB4 CTD-2020K17.4 DEF6 DMWD FAM133B GATAD1 HHEX HSD3B7 KRIT1 MAPKAPK5-AS1 MED19 NAT15 NDST2 NFKBIA P4HTM PEX1 PLEKHM1 PSMB7 RP11-298I3.1 RP11-981P6.1 RP5-1115A15.1 SH2B3 SMC4 TEAD3 TMEM116 TRIM73 UPF3A |
Angina |
1.20 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
ZNF652 |
Vitamin and mineral supplements |
1.12 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
KIAA0831 STAT6 |
Medication: Metformin |
1.32 |
5 |
2 |
4.4 |
-0.73 |
6.1e-02 |
EIF2S2P3 HHEX JAZF1 KIF11 ZFP36L2 |
Diabetes (father) |
1.23 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
EIF2S2P3 TBX6 |
Diabetes (mother) |
1.21 |
3 |
3 |
6.7 |
0.00 |
1.0e+00 |
EIF2S2P3 NFATC3 PLA2G15 |
Pack years adult smoking proportion |
0.96 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
P4HTM |
Impedance of leg (right) |
1.31 |
51 |
36 |
80.0 |
0.33 |
1.5e-02 |
AC006547.14 AC074117.10 AC103965.1 ACBD4 AMT C14orf39 C6orf164 CNP CTC-228N24.3 CTD-2020K17.4 CTSS DCST2 DOC2A EFEMP2 EP300 GIMAP7 GMIP HEMK1 HINT1 HSD3B7 ITIH4-AS1 JAZF1 LIN7C LOC595101 LRRC25 MDH2 NDFIP1 NUDT3 PACSIN1 PGC PHC2 PISD PLA2G15 PPP4C RAB5B RIN3 RNF185 RP11-231C14.4 RPN1 SEMA3B-AS1 TBX6 TEAD3 TOM1L2 TRIM73 TRIM8 TSPAN3 UBA7 USP3 ZC3HAV1 ZFP36L2 ZNF652 |
Leg fat-free mass (left) |
1.35 |
61 |
45 |
100.0 |
-0.42 |
3.5e-04 |
AC074117.10 ACBD4 ALOXE3 C14orf39 C16orf93 C17orf58 CD164 CEP85 CPEB4 CRTAP CTC-228N24.3 CTD-2020K17.4 CUX2 DCST2 DEF6 DOC2A EFEMP2 FAM133B GATAD1 GNA12 GPN3 HINT1 HIVEP3 HSD3B7 IQCH KRIT1 LIN7C LINC00674 LOC595101 LRRC37A16P NFKBIA NOSTRIN NUDT3 PACSIN1 PARP12 PEX1 PGC PHC2 PPP4C PPTC7 RAB5B REST RIN3 RMND1 RP11-231C14.4 RPN1 RSBN1L-AS1 SBNO1 SEPT2 SLC22A5 SUGT1L1 TBX6 TCTA TEAD3 TRIM73 TRIM8 UBA7 UPF3A VPS29 ZNF500 ZRANB1 |
Trunk fat percentage |
1.26 |
41 |
29 |
64.4 |
0.28 |
5.7e-02 |
ABO AC103965.1 ARL17B C16orf93 C17orf58 CENPO DOC2A GMEB2 HSD3B7 IQCH LIN7C LINC00674 LOC595101 LRRC25 LRRC37A16P MAP2K2 MAP2K5 MAST3 NOB1 PACS1 PACSIN1 PIAS1 PLEKHM1 PPARG PPP4C RHOA-IT1 RIN3 RP11-138A9.1 RP11-231C14.4 RP11-981P6.1 RP5-1115A15.1 RSBN1L-AS1 SIDT2 SMAD3 TBX6 TCTA TEAD3 TRIM73 UBA7 UPF3A WBP2 |
Hand grip strength (right) |
1.06 |
8 |
5 |
11.1 |
-0.56 |
1.1e-01 |
CENPO DOC2A IL1R2 MAX NOB1 PLEKHM1 PPP4C SLC22A5 |
Current tobacco smoking |
1.11 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
DESI1 |
Fed-up feelings |
1.06 |
5 |
2 |
4.4 |
-0.62 |
2.7e-01 |
AMT CCDC88B CLDN7 PLEKHM1 SH2B3 |
Relative age voice broke |
1.09 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
ARL17B PLEKHM1 |
Taking other prescription medications |
1.58 |
9 |
4 |
8.9 |
0.74 |
2.2e-02 |
FAM208B GSDMB IL1RL1 IQCH ORMDL3 PPP1R1B SH2B3 UBA7 ZNF652 |
Age when periods started (menarche) |
1.15 |
16 |
7 |
15.6 |
0.14 |
6.0e-01 |
AMT CENPO COG6 DOC2A HEMK1 IQCH MAST3 NFKBIA NOB1 PGC RAD54L2 RMND1 RP11-231C14.4 RP11-493E12.2 SLC25A17 TRIM73 |
Heel bone mineral density (BMD) T-score, automated (left) |
1.16 |
13 |
6 |
13.3 |
0.41 |
1.5e-01 |
AKAP11 ATP6V0D1 C11orf10 EP300 KAT5 L3MBTL2 PCNXL3 REST RHOA-IT1 RP5-1115A15.1 TCTA TRMT61A UBA7 |
High blood pressure |
1.29 |
23 |
10 |
22.2 |
0.78 |
4.2e-06 |
ABO ADRB2 ARL17B C16orf93 DOC2A HSD3B7 IQCH MAPKAPK5-AS1 NAT15 OIP5-AS1 PSMC3 RP11-138A9.1 RP11-617D20.1 RP5-1115A15.1 SH2B3 SIK2 SLC22A5 TMEM116 TRMT61A TSPY26P UBE2Z WBP2 ZNF652 |
Hayfever, allergic rhinitis or eczema |
3.81 |
62 |
49 |
108.9 |
0.86 |
6.1e-23 |
AC016747.3 AC093642.3 AC114730.7 B4GALT3 BACH2 CAMK4 CARD11 CCDC116 CD200R1 CD247 CLEC16A CLIC4 D2HGDH DEXI EFEMP2 FAM114A1 FOXO1 GLDC GPR182 GSDMB IL18RAP IL1RL1 IL2RA IL4R IL7R JMJD5 KIAA1109 KIF3A LCLAT1 LRRC32 MED24 NDFIP1 OIP5-AS1 ORMDL3 PCNXL3 PEX13 PLGRKT POLI PPP1R1B PRKCQ PSMB7 RAB5B RGS14 RNASEH2C RP11-396B14.2 RP11-876N24.4 RP5-1115A15.1 SIK2 SLC25A46 SLC9A2 SMAD3 SMAD4 SMARCE1 SPATA5 SPPL3 STAT6 THRA TSGA10IP TSLP UBAC2 WDR36 ZNF652 |
Medication: Atenolol |
1.16 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
SH2B3 |
Medication: Levothyroxine sodium |
1.92 |
19 |
12 |
26.7 |
0.60 |
5.5e-03 |
ADAM1A BACH2 C11orf10 CCDC88B EFCAB13 FADS1 FADS2 FAM208B LRRC25 MAPKAPK5-AS1 MYNN RAB5B RASGRP1 SEPT2 SH2B3 TCTN1 TMEM116 TMEM131 VPS29 |
Sitting height |
1.07 |
72 |
59 |
131.1 |
-0.25 |
3.0e-02 |
AC074212.6 AC103965.1 ACBD4 ALOXE3 ARL17B ATP9A BRD3 C11orf10 C14orf39 C6orf81 CCDC116 CD164 CDIP1 CENPO CEP85 CHSY3 CRTAP DLEU1 DMWD EBPL FADS1 FAM133B FGF11 GATAD1 GIGYF1 GNA12 IFI35 JAZF1 KIF17 KRIT1 MAX NOB1 NOSTRIN NOV NUDT3 P4HTM PACSIN1 PARP12 PEX1 PGC PLEKHM1 PPARA PRTFDC1 PSMC3 PUS10 REST RHOA-IT1 RSBN1L-AS1 SBNO1 SEC16A SEPT2 SIX5 SLC11A2 SLC13A4 SLC22A5 STAT6 STOX1 TCTA TEAD3 TFPI TRPC1 UBE2Z UPF3A USP3 WAC-AS1 ZNF414 ZNF425 ZNF500 ZNF568 ZNF574 ZNF652 ZRANB1 |
High blood pressure (mother) |
1.11 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
UBE2Z |
Body mass index (BMI) |
1.24 |
43 |
26 |
57.8 |
-0.05 |
7.2e-01 |
AC006547.14 ACTR1B C16orf93 C17orf107 C17orf58 CENPO DOC2A EFEMP2 GPN3 HSD3B7 IQCH ITIH4-AS1 LIN7C LINC00674 LOC595101 MAP2K2 MAP2K5 MAST3 NOB1 NUDT3 OAS3 PACSIN1 PHC2 PNPO PPP4C PPTC7 RAB5B RP11-231C14.4 RP11-981P6.1 RP5-1115A15.1 SIDT2 SMAD3 TBX6 TCTA TEAD3 TFPI TNFRSF14 TRIM73 TRIM8 TRMT61A UBA7 USP3 VPS29 |
Impedance of leg (left) |
1.29 |
52 |
39 |
86.7 |
0.26 |
5.0e-02 |
AC006547.14 AC074117.10 AC103965.1 ACBD4 AMT C6orf164 CNP CTC-228N24.3 CTD-2020K17.4 CTSS DCST2 DOC2A EP300 GIMAP7 GMIP HEMK1 HINT1 HSD3B7 ITIH4-AS1 JAZF1 LIN7C LOC595101 LPP LRRC25 NDFIP1 NUDT3 PACSIN1 PARP12 PGC PHC2 PISD PLA2G15 PLEKHM1 PPP4C RAB5B RIN3 RNF185 RP11-231C14.4 RPN1 SEMA3B-AS1 TBX6 TEAD3 TOM1L2 TP53INP1 TRIM73 TRIM8 TSPAN3 UBA7 USP3 ZC3HAV1 ZFP36L2 ZNF652 |
Leg predicted mass (left) |
1.34 |
60 |
44 |
97.8 |
-0.42 |
4.3e-04 |
AC074117.10 ACBD4 ALOXE3 C14orf39 C16orf93 C17orf58 CD164 CEP85 CPEB4 CRTAP CTC-228N24.3 CTD-2020K17.4 CUX2 DCST2 DEF6 DOC2A EFEMP2 FAM133B GATAD1 GNA12 GPN3 HINT1 HIVEP3 HSD3B7 IQCH KRIT1 LIN7C LINC00674 LOC595101 LRRC37A16P NFKBIA NOSTRIN NUDT3 PACSIN1 PARP12 PEX1 PGC PHC2 PPP4C PPTC7 RAB5B RIN3 RMND1 RP11-231C14.4 RPN1 RSBN1L-AS1 SBNO1 SEPT2 SLC22A5 SUGT1L1 TBX6 TCTA TEAD3 TRIM73 TRIM8 UBA7 UPF3A VPS29 ZNF500 ZRANB1 |
Trunk fat mass |
1.28 |
43 |
34 |
75.6 |
0.10 |
5.1e-01 |
AC103965.1 ARL17B C16orf93 C17orf58 CD164 CENPO DOC2A FAM133B GNA12 GPN3 HIVEP3 HSD3B7 IQCH LIN7C LINC00674 LOC595101 LRRC25 LRRC37A16P MAP2K2 MAP2K5 MAST3 MRPS21 NOB1 PACSIN1 PAPD7 PIAS1 PPARG PPP4C PPTC7 RHOA-IT1 RP11-138A9.1 RP11-231C14.4 RP11-981P6.1 RP5-1115A15.1 RSBN1L-AS1 SIDT2 SMAD3 TBX6 TCTA TRIM73 UBA7 UPF3A WBP2 |
Waist circumference |
1.30 |
31 |
26 |
57.8 |
0.04 |
8.2e-01 |
C16orf93 C17orf58 CENPO DOC2A HINT1 HSD3B7 IQCH LIN7C LINC00674 LOC595101 LRRC25 LRRC37A16P MAP2K2 MAP2K5 MAST3 NOB1 PACSIN1 PHC2 PPP4C RP11-231C14.4 RP11-981P6.1 SIDT2 SMAD3 TBX6 TCTA TEAD3 TFPI TRIM73 UBA7 ZNF500 ZNHIT3 |
Number of incorrect matches in round |
1.06 |
5 |
5 |
11.1 |
0.97 |
1.7e-03 |
DOC2A LOC595101 PPP4C RP11-231C14.4 TBX6 |
Past tobacco smoking |
1.05 |
3 |
2 |
4.4 |
0.17 |
8.3e-01 |
IQCH PHC2 SH2B3 |
Alcohol usually taken with meals |
1.17 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RMI1 |
Nervous feelings |
1.09 |
7 |
2 |
4.4 |
-0.39 |
3.9e-01 |
ARL17B DOC2A FRAT2 L3MBTL2 LIN7C PLEKHM1 PPP4C |
Frequency of tenseness / restlessness in last 2 weeks |
1.10 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
AMT ARL17B PLEKHM1 |
Hearing difficulty/problems with background noise |
1.00 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
PLEKHM1 |
Hair/balding pattern: Pattern 2 |
1.09 |
4 |
2 |
4.4 |
-0.17 |
8.3e-01 |
ARL17B C21orf96 CLIC4 PLEKHM1 |
Had menopause |
0.93 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
IFI35 |
Forced vital capacity (FVC) |
1.07 |
27 |
20 |
44.4 |
-0.27 |
1.7e-01 |
ARL17B C6orf81 CD164 CENPO CEP85 CLDN7 CTC-228N24.3 CTSS DEF6 FAM133B GATAD1 GMEB2 GNA12 GOLPH3L MAP2K2 NOB1 NUDT3 PACSIN1 PLEKHM1 REST RIN3 SEPT2 SRPK1 TEAD3 UBE2Z WAC-AS1 ZNF574 |
Heel bone mineral density (BMD) T-score, automated (right) |
1.19 |
17 |
8 |
17.8 |
0.24 |
3.3e-01 |
AKAP11 AMT ARHGEF19-AS1 ATP6V0D1 C11orf10 EP300 FADS2 GATAD1 KAT5 L3MBTL2 MAP3K11 PCNXL3 RHOA-IT1 RP5-1115A15.1 TCTA TRMT61A UBA7 |
Ever unenthusiastic/disinterested for a whole week |
1.16 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
PLEKHM1 |
Qualifications: None of the above |
0.99 |
7 |
3 |
6.7 |
-0.09 |
8.5e-01 |
AMT CKM P4HTM RAB5B RANBP6 SBNO1 UBA7 |
Mouth/teeth dental problems |
1.09 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
IRF5 |
Heart attack |
1.10 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
ZFP36L2 ZNF652 |
Allergy |
4.58 |
81 |
62 |
137.8 |
-0.83 |
1.5e-27 |
ABO AC016747.3 AC093642.3 AC114730.7 AHI1 B4GALT3 BACH2 CAMK4 CARD11 CD200R1 CD247 CLEC16A CLIC4 D2HGDH DEF6 DEXI EFEMP2 EP300 ERMP1 FADS2 FAM114A1 FOXO1 FPR3 GLDC GNPDA1 GPR182 GSDMB HHEX IL18RAP IL1R2 IL1RL1 IL2RA IL4R IL7R IQCH JAZF1 JMJD5 KIAA1109 KIAA1432 KIF11 KIF3A L3MBTL2 LCLAT1 LRRC32 MED24 NDFIP1 NRROS OIP5-AS1 ORMDL3 PEX13 PLGRKT POLI PPP1R1B PRKCQ PSMB7 RAB5B RBBP8 RGS14 RIN3 RMI2 RNASEH2C RP11-396B14.2 RP11-876N24.4 RP5-1115A15.1 SIK2 SLC22A5 SLC25A46 SLC9A2 SMAD3 SMAD4 SMARCE1 SPATA5 SPPL3 STAT6 THRA TLR6 TNFRSF14 TSLP UBAC2 WDR36 ZNF652 |
Diabetes (self-reported) |
1.30 |
6 |
5 |
11.1 |
-0.12 |
7.6e-01 |
EIF2S2P3 HHEX JAZF1 KIF11 TCTA UBA7 |
Hayfever/allergic rhinitis (self-reported) |
2.38 |
22 |
16 |
35.6 |
0.92 |
7.8e-12 |
AC114730.7 B4GALT3 BACH2 CD247 D2HGDH FAM114A1 GLDC GPR182 GSDMB IL18RAP IL1RL1 IL7R KIAA1109 LRRC32 ORMDL3 RP11-396B14.2 SLC25A46 SLC9A2 SMAD3 SPATA5 TSLP WDR36 |
Medication: Simvastatin |
1.23 |
5 |
3 |
6.7 |
0.05 |
9.3e-01 |
CARM1 DMWD LPL TOMM40 ZNF259 |
Fluid intelligence score |
0.94 |
3 |
2 |
4.4 |
0.00 |
1.0e+00 |
FRAT2 TCTA UBA7 |
Illnesses of siblings |
1.20 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
HSD3B7 SH2B3 |
Neuroticism score |
1.13 |
7 |
4 |
8.9 |
-0.59 |
1.2e-01 |
AHSA2 ARL17B KCTD10 L3MBTL2 PLCL2 PLEKHM1 RP5-1115A15.1 |
Weight |
1.36 |
52 |
45 |
100.0 |
-0.21 |
1.2e-01 |
ACBD4 C14orf39 C16orf93 C17orf58 CD164 CUX2 DOC2A EFEMP2 FAM133B GATAD1 GNA12 GPN3 HINT1 HIVEP3 HSD3B7 IQCH KRIT1 LIN7C LINC00674 LOC595101 LRRC37A16P MAP2K5 MAST3 NOSTRIN NUDT3 PACSIN1 PAPD7 PEX1 PGC PHC2 PIAS1 PPP4C PPTC7 RAB5B RP11-231C14.4 RP11-617D20.1 RP11-981P6.1 RSBN1L-AS1 SEPT2 SIDT2 SLC22A5 SMAD3 TBX6 TCTA TEAD3 TNFRSF14 TRIM73 TRIM8 UBA7 UPF3A VPS29 ZNF500 |
Impedance of arm (right) |
1.30 |
61 |
43 |
95.6 |
0.25 |
4.2e-02 |
ABO AC006547.14 AC074117.10 AC103965.1 ACTR1B AMT ARL17B ARNT C12orf24 C6orf164 CTD-2020K17.4 CTSS DCST2 DOC2A EFEMP2 EIF4ENIF1 EP300 GMIP GPN3 HEMK1 HIGD1A HSD3B7 ITIH4-AS1 JAZF1 L3MBTL2 LCLAT1 LIN7C LOC595101 LRRC25 LRRC32 MED24 NUDT3 ORMDL3 P4HTM PACSIN1 PHC2 PISD PLA2G15 PLEKHM1 PPP4C PPTC7 PSMB7 RAB5B RAB7A RHOA-IT1 RIN3 RMI1 RNF185 RNF215 RP11-231C14.4 RP11-85K15.2 SEMA3B-AS1 TBX6 TEAD3 TRIM8 TRMT61A TSPAN3 UBA7 UPF3A VPS29 ZNF652 |
Arm fat percentage (right) |
1.22 |
33 |
27 |
60.0 |
0.10 |
5.5e-01 |
ABO C16orf93 C17orf58 CENPO DOC2A GMEB2 HSD3B7 IQCH LIN7C LINC00674 LOC595101 LRRC25 LRRC37A16P MAP2K2 MAP2K5 MAST3 NOB1 OIP5-AS1 PPARG PPP4C RP11-138A9.1 RP11-231C14.4 RP11-981P6.1 RP5-1115A15.1 SIDT2 SMAD3 TBX6 TCTA TEAD3 TRIM73 UBA7 USP3 WBP2 |
Trunk fat-free mass |
1.40 |
70 |
55 |
122.2 |
-0.46 |
2.8e-05 |
ABO AC074117.10 ACBD4 ALOXE3 C14orf39 C6orf81 CD164 CENPO CEP85 CTC-228N24.3 CTD-2020K17.4 CUX2 DEF6 DESI1 DOC2A FAM133B FGF11 FXR2 GATAD1 GNA12 GPN3 HINT1 HSD3B7 JAZF1 KRIT1 LBX2-AS1 LIN7C LOC595101 LRRC25 MAX NFATC3 NFKBIA NOSTRIN NUDT3 PACSIN1 PAPD7 PARP12 PEX1 PGC PHC2 PPP4C PPTC7 PSMB7 PSMC3 RAB5B REST RIN3 RMND1 RNF185 RP11-231C14.4 SBNO1 SEC16A SEPT2 SH2B3 SLC22A5 SRPK1 STAT6 SUGT1L1 TBX6 TCTA TEAD3 TPSB2 TRIM8 UBA7 UBE2Z VPS29 WAC-AS1 ZNF414 ZNF500 ZRANB1 |
Hip circumference |
1.32 |
52 |
36 |
80.0 |
-0.18 |
1.9e-01 |
C12orf24 C16orf93 C17orf58 CD164 CENPO CPEB4 DOC2A FAM133B GATAD1 GNA12 GPN3 HIVEP3 HSD3B7 IQCH KCNJ2 LIN7C LINC00674 LOC541471 LOC595101 LRRC37A16P MAP2K2 MAPKAPK5-AS1 MAST3 MRPS21 NOB1 NUDT3 OAS3 PACSIN1 PEX1 PGC PHC2 PIAS1 PPP4C PPTC7 RAD9B RP11-138A9.1 RP11-231C14.4 RP11-617D20.1 RP11-981P6.1 RSBN1L-AS1 SEPT2 SH2B3 SMAD3 TBX6 TCTA TEAD3 TRIM73 TRIM8 UBA7 UPF3A VPS29 WBP2 |
Alcohol intake versus 10 years previously |
1.05 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
TCTA UBA7 UQCRQ |
Father's age at death |
1.27 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
SBNO1 SH2B3 |
Worrier / anxious feelings |
0.97 |
6 |
3 |
6.7 |
-0.18 |
7.4e-01 |
ITIH4-AS1 KCTD10 L3MBTL2 PLEKHM1 SEMA3B-AS1 TEAD3 |
Frequency of tiredness / lethargy in last 2 weeks |
1.07 |
6 |
2 |
4.4 |
-0.50 |
3.1e-01 |
AMT KCTD10 LIN7C P4HTM RHOA-IT1 UBE2Z |
Hair/balding pattern: Pattern 3 |
0.96 |
3 |
3 |
6.7 |
0.00 |
1.0e+00 |
ARL17B C21orf96 PLEKHM1 |
Number of live births |
1.09 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
C11orf10 |
Forced expiratory volume in 1-second (FEV1) |
1.10 |
23 |
16 |
35.6 |
-0.43 |
4.3e-02 |
ARL17B C20orf112 C6orf81 CD164 CENPO CEP85 CTSS DEF6 FBXO38 GMEB2 GOLPH3L NDST2 NFKBIA NOB1 PACSIN1 PLEKHM1 RAB5B REST RIN3 RNF185 SRPK1 TEAD3 WAC-AS1 |
Pulse rate |
1.17 |
7 |
4 |
8.9 |
-0.13 |
7.8e-01 |
AMT C11orf10 FADS1 FADS2 GIGYF1 P4HTM RHOA-IT1 |
Qualifications: A levels/AS levels or equivalent |
0.99 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
TCTA UBA7 |
Mouth/teeth dental problems: Dentures |
1.07 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
B4GALT3 |
Asthma |
4.34 |
60 |
49 |
108.9 |
0.82 |
8.4e-21 |
AC074212.6 AC093642.3 AC114730.11 AC114730.7 AHI1 B4GALT3 BACH2 C11orf10 CARM1 CD247 CLEC16A CTD-3203P2.1 D2HGDH DEF6 DEXI DMWD EIF2S2P3 FADS2 FAM114A1 FPR3 GLDC GPR182 GSDMB HHEX IL18RAP IL1RL1 IL4R IL7R IQCH JMJD5 KIAA1109 KIAA1432 KIF11 KIF3A LRRC32 MED24 NDFIP1 NRROS ORMDL3 POLI PPP1R1B RAB5B RIN3 RP11-396B14.2 RP11-876N24.4 RP5-1115A15.1 SIK2 SIX5 SLC22A5 SLC25A46 SLC9A2 SMAD3 SPPL3 STAT6 TBX6 THRA TSLP UBAC2 WDR36 ZNF652 |
Medication: Ibuprofen (e.g. Nurofen) |
0.99 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
STAT6 |
Medication: Cholesterol lowering |
1.19 |
4 |
3 |
6.7 |
-0.48 |
5.2e-01 |
CARM1 LPL TOMM40 ZNF259 |
Depression (self-reported) |
0.99 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RP5-1115A15.1 |
Illnesses of mother |
1.07 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
MED24 UBE2Z |
Forced expiratory volume in 1-second (FEV1), Best measure |
1.10 |
20 |
14 |
31.1 |
-0.42 |
6.2e-02 |
ARL17B C20orf112 C5orf34 C6orf81 CD164 CEP85 CTSS DEF6 FBXO38 GMEB2 GOLPH3L NDST2 NOB1 PACSIN1 PLEKHM1 RAB5B REST RIN3 TEAD3 WAC-AS1 |
Impedance of arm (left) |
1.29 |
52 |
44 |
97.8 |
0.17 |
2.1e-01 |
ABO AC006547.14 AC074117.10 AC103965.1 ACBD4 ACTR1B AMT ARL17B ARNT CTD-2020K17.4 CTSS DOC2A EFEMP2 EIF4ENIF1 EP300 GMIP GPN3 HEMK1 HIGD1A HSD3B7 ITIH4-AS1 JAZF1 L3MBTL2 LIN7C LOC595101 LRRC25 LRRC32 NUDT3 P4HTM PHC2 PISD PLEKHM1 PPP4C PSMB7 RAB5B RHOA-IT1 RIN3 RMI1 RNF185 RNF215 RP11-231C14.4 RP11-85K15.2 SEMA3B-AS1 SH2B3 TBX6 TEAD3 TNIP2 TRIM8 TSPAN3 UBA7 VPS29 ZNF652 |
Arm fat mass (right) |
1.28 |
38 |
26 |
57.8 |
-0.08 |
6.1e-01 |
C16orf93 C17orf58 CD164 CENPO DOC2A GPN3 HINT1 HSD3B7 IQCH LIN7C LINC00674 LOC595101 LRRC25 LRRC37A16P MAP2K2 MAP2K5 MAST3 NOB1 NUDT3 OAS3 PACSIN1 PHC2 PPP4C PPTC7 RAB5B RP11-231C14.4 RP11-981P6.1 RP5-1115A15.1 RSBN1L-AS1 SIDT2 SMAD3 TBX6 TCTA TEAD3 TRIM73 TRIM8 UBA7 VPS29 |
Trunk predicted mass |
1.40 |
72 |
54 |
120.0 |
-0.47 |
8.9e-06 |
ABO AC074117.10 ACBD4 ALOXE3 C14orf39 C6orf81 CD164 CDIP1 CENPO CEP85 CTC-228N24.3 CTD-2020K17.4 CUX2 DEF6 DESI1 DOC2A EFEMP2 FAM133B FGF11 FXR2 GATAD1 GNA12 GPN3 HINT1 HSD3B7 JAZF1 KRIT1 LIN7C LOC595101 LRRC25 MAX NFATC3 NFKBIA NOSTRIN NUDT3 PACSIN1 PAPD7 PARP12 PEX1 PGC PHC2 PPP4C PPTC7 PRTFDC1 PSMB7 PSMC3 RAB5B REST RIN3 RMND1 RNF185 RP11-231C14.4 SBNO1 SEC16A SEPT2 SH2B3 SLC22A5 SRPK1 STAT6 SUGT1L1 TBX6 TCTA TEAD3 TPSB2 TRIM8 UBA7 UBE2Z VPS29 WAC-AS1 ZNF414 ZNF500 ZRANB1 |
Standing height |
1.19 |
119 |
94 |
208.9 |
-0.17 |
5.0e-02 |
AC021860.1 AC074212.6 AC103965.1 ACBD4 ADO ALOXE3 ARHGEF19-AS1 ARL17B BRD3 C11orf10 C17orf58 C6orf81 CD164 CENPO CEP85 COG6 CRTAP CTD-2020K17.4 CUX2 DEF6 DESI1 DLEU1 DMWD DOC2A EBPL EFCAB13 EGR2 FADS1 FADS2 FAM114A1 FAM133B FGF11 FLJ13197 FXR2 GATAD1 GIGYF1 GNA12 HEMK1 HINT1 HIVEP3 IFI35 IL1R2 IQCH ITIH4-AS1 JAZF1 KIF17 KRIT1 LBX2-AS1 LINC00674 LRRC37A16P MAP2K2 MAP3K11 MAX MKRN2 MRPS21 NFKBIA NOB1 NOSTRIN NUCB2 NUDT3 OIP5-AS1 P4HTM PACSIN1 PAPD7 PARP12 PEX1 PGC PHC2 PLEKHM1 PPARA PPP4C PSMC3 PTEN PUS10 QPCTL RBBP8 REST RGS14 RMI1 RMND1 RNASEH2C RP11-231C14.4 RP11-617D20.1 RP5-1085F17.3 RP5-1115A15.1 RPL32P3 SBNO1 SEC16A SEPT2 SH2B3 SIX5 SLC11A2 SLC13A4 SLC22A5 SLC25A17 SPPL3 STAT6 STOX1 SUGT1L1 TBX6 TCTA TEAD3 TPSB2 TRMT61A TRPC1 TSEN2 TSGA10IP TSPAN3 UBE2Z UPF3A USP3 WAC-AS1 ZNF414 ZNF500 ZNF568 ZNF574 ZNF652 ZNF786 ZRANB1 |
Breastfed as a baby |
1.02 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
PSMB7 |
Tense / 'highly strung' |
1.07 |
3 |
2 |
4.4 |
0.00 |
1.0e+00 |
L3MBTL2 RP5-1115A15.1 ZSCAN29 |
Hair/balding pattern: Pattern 4 |
1.00 |
8 |
5 |
11.1 |
0.66 |
7.3e-02 |
ARL17B ATP6V0D1 C11orf10 CLIC4 FADS1 IQCH PLEKHM1 RP5-1115A15.1 |
Birth weight of first child |
1.22 |
4 |
4 |
8.9 |
-0.49 |
5.1e-01 |
C6orf81 RP11-158M2.3 SH2B3 TEAD3 |
Peak expiratory flow (PEF) |
1.06 |
10 |
4 |
8.9 |
0.22 |
5.1e-01 |
ABO ARL17B C6orf81 DEF6 DLEU1 FBXO38 PLEKHM1 REST TRPC1 ZFP36L2 |
Ever highly irritable/argumentative for 2 days |
1.08 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
UBA7 |
Qualifications: O levels/GCSEs or equivalent |
0.91 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
SBNO1 |
Blood clot in the leg (DVT) |
1.78 |
1 |
1 |
2.2 |
-0.98 |
2.1e-02 |
ABO |
Medication: Paracetamol |
1.12 |
3 |
3 |
6.7 |
0.00 |
1.0e+00 |
ARL17B PLEKHM1 STAT6 |
Headache pain in last month |
1.25 |
8 |
6 |
13.3 |
-0.75 |
3.1e-02 |
ACBD4 ARL17B FAM216A PLEKHM1 PPP1CC RAB5B SIX5 STAT6 |
Medication for cholesterol, blood pressure or diabetes |
1.17 |
5 |
4 |
8.9 |
-0.63 |
2.6e-01 |
SH2B3 SIK2 TSPY26P ZNF259 ZNF652 |
Gout (self-reported) |
1.21 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
MAP3K11 PCNXL3 SH2B3 |
Hypothyroidism/myxoedema (self-reported) |
2.01 |
24 |
14 |
31.1 |
0.53 |
6.4e-03 |
AC114730.7 ADAM1A BACH2 C11orf10 CCDC88B CD226 CD247 CHD7 EFCAB13 FADS1 FAM208B FCHO2 LRRC25 MAPKAPK5-AS1 PSMB7 RAB5B RASGRP1 SEPT2 SESN1 SH2B3 SSTR3 TCTN1 TMEM131 VPS29 |
Medication: Amlodipine |
1.20 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
FLJ13197 |
Medication: Ventolin 100micrograms inhaler |
2.54 |
15 |
9 |
20.0 |
0.92 |
1.2e-07 |
AC114730.7 AHI1 D2HGDH DEXI FOXO1 GLDC GSDMB IL18RAP IL1RL1 LRRC32 ORMDL3 PPP1R1B SMAD3 STAT6 ZNF652 |
Birth weight |
1.32 |
13 |
9 |
20.0 |
-0.16 |
5.5e-01 |
C6orf81 CLDN7 EIF2S2P3 EIF4ENIF1 GNA12 HHEX KIF11 RP11-158M2.3 RP5-1085F17.3 SESN1 SH2B3 SIK2 TEAD3 |
High blood pressure (siblings) |
1.18 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
HSD3B7 SH2B3 |
Forced vital capacity (FVC), Best measure |
1.05 |
24 |
18 |
40.0 |
-0.31 |
1.5e-01 |
ARL17B ARNT C5orf34 C6orf81 CD164 CENPO CEP85 CTC-228N24.3 CTSS DEF6 FAM133B GMEB2 GNA12 GOLPH3L NOB1 PACSIN1 PLEKHM1 PSMC3 REST RIN3 SEPT2 SRPK1 TEAD3 WAC-AS1 |
Body fat percentage |
1.27 |
38 |
33 |
73.3 |
0.35 |
2.1e-02 |
AC103965.1 ARL17B C16orf93 C17orf58 CENPO CTC-228N24.3 CTSS DOC2A GMEB2 HSD3B7 IQCH LIN7C LINC00674 LOC595101 LRRC25 LRRC37A16P MAP2K2 MAP2K5 MAST3 MRPS21 NOB1 OIP5-AS1 PPARG PPP4C RHOA-IT1 RIN3 RP11-138A9.1 RP11-231C14.4 RP11-981P6.1 RP5-1115A15.1 RSBN1L-AS1 SIDT2 SMAD3 TBX6 TCTA TEAD3 TRIM73 UBA7 |
Leg fat percentage (right) |
1.28 |
35 |
23 |
51.1 |
0.53 |
5.7e-04 |
ATP9A C17orf107 C17orf58 CENPO CKM CTC-228N24.3 DLEU1 DOC2A GMEB2 HSD3B7 IQCH LIN7C LINC00674 LRRC25 LRRC37A16P MAP2K2 MAP2K5 MAST3 MRPS21 NOB1 OIP5-AS1 PLGRKT PSMC3 RIN3 RP11-138A9.1 RP11-231C14.4 RP11-981P6.1 RP5-1115A15.1 SIDT2 SMAD3 TCTA TEAD3 TFPI TRIM73 UBA7 |
Arm fat-free mass (right) |
1.39 |
62 |
46 |
102.2 |
-0.46 |
5.1e-05 |
ABO AC006547.14 AC074117.10 ACBD4 ADAM1A ALOXE3 C12orf24 C14orf39 C17orf58 C6orf81 CD164 CEP85 CTD-2020K17.4 CUX2 DEF6 DOC2A EFEMP2 FAM133B GATAD1 GNA12 GPN3 HINT1 HIVEP3 HSD3B7 KRIT1 LIN7C LOC595101 MAX NFKBIA NOSTRIN NUDT3 PACSIN1 PAPD7 PARP12 PEX1 PGC PHC2 PPP4C PPTC7 PSMB7 RAB5B RAPGEF1 REST RIN3 RNF185 RP11-231C14.4 RSBN1L-AS1 SBNO1 SEC16A SEPT2 SH2B3 SLC22A5 TBX6 TCTA TEAD3 TRIM8 UBA7 VPS29 WAC-AS1 ZNF414 ZNF500 ZRANB1 |
Comparative body size at age 10 |
1.29 |
17 |
10 |
22.2 |
-0.15 |
5.3e-01 |
C16orf93 C5orf34 CENPO DOC2A IQCH LIN7C LOC595101 LRRC29 MAP3K11 NEURL1B PGC RP11-231C14.4 SMAD3 TBX6 TEAD3 TSGA10IP ZNF652 |
Worry too long after embarrassment |
1.00 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
IQCH PLEKHM1 |
Wheeze or whistling in the chest in last year |
2.50 |
29 |
19 |
42.2 |
0.90 |
1.8e-13 |
AC114730.11 AC114730.7 BACH2 CD247 CLEC16A D2HGDH DEXI GLDC GMEB2 GPR182 GSDMB IL18RAP IL1R2 IL1RL1 KIAA1432 LIN7C LRRC32 LRRC37A16P MED24 ORMDL3 PPP1R1B RP11-396B14.2 SIK2 SMAD3 TCTA THRA TSLP UBA7 UBAC2 |
Age at first live birth |
1.07 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
UBA7 |
Health satisfaction |
1.07 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SLC13A4 |
Qualifications: College or University degree |
1.01 |
15 |
10 |
22.2 |
0.29 |
2.9e-01 |
AMT ARL17B CKM DR1 HSD3B7 LRRC25 MAST3 PLEKHM1 RAB5B RANBP6 RP11-298I3.1 TCTA TNIP2 TRMT61A UBA7 |
Medication for pain relief, constipation, heartburn |
1.08 |
3 |
2 |
4.4 |
0.00 |
1.0e+00 |
PLEKHM1 SBNO1 STAT6 |
Medication: Blood pressure |
1.18 |
4 |
4 |
8.9 |
0.86 |
1.4e-01 |
SH2B3 SIK2 TSPY26P ZNF652 |
Angina (self-reported) |
1.18 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ZNF652 |
Migraine (self-reported) |
1.18 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
STAT6 |
Medication: Ibuprofen |
1.01 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
STAT6 |
Medication: Allopurinol |
1.16 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
MAP3K11 PCNXL3 |
Medication: Seretide 50 evohaler |
1.75 |
3 |
1 |
2.2 |
0.94 |
5.8e-02 |
IL18RAP IL1RL1 SMAD3 |
Mean time to correctly identify matches |
1.09 |
5 |
3 |
6.7 |
0.88 |
4.7e-02 |
MAPKAPK5-AS1 NBEAL2 PISD RMI1 SH2B3 |
Whole body fat mass |
1.29 |
44 |
27 |
60.0 |
0.03 |
8.5e-01 |
ARL17B C16orf93 C17orf58 CD164 CENPO DOC2A GNA12 GPN3 HIVEP3 HSD3B7 IQCH LIN7C LINC00674 LOC595101 LRRC25 LRRC37A16P MAP2K2 MAP2K5 MAST3 MRPS21 NOB1 OAS3 PACSIN1 PAPD7 PHC2 PIAS1 PPARG PPP4C PPTC7 RAB5B RHOA-IT1 RP11-231C14.4 RP11-981P6.1 RP5-1115A15.1 RSBN1L-AS1 SIDT2 SMAD3 TBX6 TCTA TRIM73 TRIM8 UBA7 UPF3A VPS29 |
Leg fat mass (right) |
1.30 |
40 |
30 |
66.7 |
-0.05 |
7.7e-01 |
C16orf93 C17orf58 CD164 CENPO DOC2A EFEMP2 GPN3 HSD3B7 IQCH LIN7C LINC00674 LOC595101 LRRC25 LRRC37A16P MAP2K2 MAP2K5 MAST3 MRPS21 NOB1 NUDT3 PACSIN1 PHC2 PPP4C PPTC7 RAB5B RP11-231C14.4 RP11-981P6.1 RP5-1115A15.1 RSBN1L-AS1 SIDT2 SMAD3 TBX6 TCTA TEAD3 TFPI TNFRSF14 TRIM73 TRIM8 UBA7 VPS29 |
Arm predicted mass (right) |
1.40 |
64 |
46 |
102.2 |
-0.44 |
7.9e-05 |
ABO AC006547.14 AC074117.10 ACBD4 ADAM1A ALOXE3 C12orf24 C14orf39 C16orf93 C17orf58 C6orf81 CD164 CEP85 CTD-2020K17.4 CUX2 DCST2 DEF6 DOC2A EFEMP2 FAM133B GATAD1 GNA12 GPN3 HINT1 HSD3B7 KRIT1 LIN7C LINC00674 LOC595101 MAX NFATC3 NFKBIA NOSTRIN NUDT3 PACSIN1 PAPD7 PARP12 PEX1 PGC PHC2 PPP4C PPTC7 PSMB7 RAB5B RAPGEF1 REST RIN3 RP11-231C14.4 SBNO1 SEC16A SEPT2 SH2B3 SLC22A5 TBX6 TCTA TEAD3 TRIM8 UBA7 UBE2Z VPS29 WAC-AS1 ZNF414 ZNF500 ZRANB1 |
Pulse rate, automated reading |
1.38 |
24 |
15 |
33.3 |
0.07 |
7.4e-01 |
AMT C11orf10 C12orf24 C16orf93 CSTA FADS1 FADS2 GIGYF1 GPN3 ITPRIPL1 MYRF P4HTM PGC PPTC7 RAB5B RAD9B RHOA-IT1 SLC13A4 SLC7A8 TCTA TFPI TOM1L2 UBA7 VPS29 |
Alcohol intake frequency. |
1.02 |
12 |
6 |
13.3 |
-0.57 |
5.3e-02 |
AC074117.10 ADH1B ARL17B C16orf93 DOC2A HSD3B7 PLEKHM1 PPP4C SBNO1 STAT6 TBX6 UBA7 |
Comparative height size at age 10 |
1.15 |
58 |
39 |
86.7 |
-0.30 |
1.4e-02 |
AC010883.5 AC103965.1 ALOXE3 C14orf174 C17orf58 C6orf81 CENPO CEP85 CUX2 DEF6 DLEU1 DOC2A FAM133B GATAD1 GNA12 IQCH JAZF1 KIF11 KIF17 KRIT1 LBX2-AS1 LINC00674 LRRC37A16P MAP2K2 MAX NFKBIA NOSTRIN NUCB2 P4HTM PACSIN1 PAPD7 PEX1 PLEKHM1 PPP4C PSMC3 RBBP8 REST RMI1 RP11-231C14.4 RP5-1085F17.3 SBNO1 SEC16A SEPT2 SH2B3 SIX5 SLC13A4 SLC22A5 SUGT1L1 TBX6 TEAD3 TSPAN3 UBE2Z UPF3A ZFP36L2 ZNF414 ZNF500 ZNF568 ZRANB1 |
Number of full sisters |
1.01 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
TNIP2 |
Overall health rating |
1.07 |
8 |
4 |
8.9 |
0.92 |
1.9e-04 |
AMT C17orf58 LINC00674 TCTA TOM1L2 TSPY26P UBA7 ZNF652 |
Chest pain or discomfort |
1.12 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
IL1RL1 THRA |
Age at last live birth |
1.02 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
UBA7 |
Leg pain on walking |
0.99 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
UBA7 |
Qualifications: NVQ or HND or HNC or equivalent |
1.19 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
UBA7 |
Hypertension (Self-reported) |
1.28 |
21 |
10 |
22.2 |
0.82 |
5.8e-07 |
ABO AC021860.1 ADRB2 ARL17B FLJ13197 HSD3B7 MAPKAPK5-AS1 NAT15 OIP5-AS1 PSMC3 RP11-138A9.1 RP11-617D20.1 RP5-1115A15.1 SH2B3 SIK2 SLC22A5 TMEM116 TP53INP1 TSPY26P WBP2 ZNF652 |
Illnesses of father: Heart disease |
1.13 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SMAD3 |
Smoking status: Previous |
1.03 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SH2B3 |
Forced expiratory volume in 1-second (FEV1), predicted |
1.12 |
12 |
8 |
17.8 |
-0.42 |
1.8e-01 |
AC103965.1 C6orf81 DEF6 FAM133B GNA12 JAZF1 NOSTRIN PACSIN1 PGC SEC16A SLC22A5 TEAD3 |
Whole body fat-free mass |
1.39 |
67 |
51 |
113.3 |
-0.43 |
1.2e-04 |
AC074117.10 ACBD4 ALOXE3 C14orf39 C17orf58 C6orf81 CD164 CEP85 CTC-228N24.3 CTD-2020K17.4 CUX2 DCST2 DEF6 DESI1 DOC2A EFEMP2 FAM133B GATAD1 GNA12 GPN3 HINT1 HIVEP3 HSD3B7 KRIT1 LIN7C LOC595101 MAX NFATC3 NFKBIA NOSTRIN NUDT3 PACSIN1 PAPD7 PARP12 PEX1 PGC PHC2 PPP4C PPTC7 PSMC3 RAB5B REST RIN3 RMND1 RNF185 RP11-231C14.4 RP11-617D20.1 RSBN1L-AS1 SBNO1 SEC16A SEPT2 SH2B3 SLC22A5 STAT6 SUGT1L1 TBX6 TCTA TEAD3 TRIM8 UBA7 UBE2Z UPF3A VPS29 WAC-AS1 ZNF414 ZNF500 ZRANB1 |
Leg fat-free mass (right) |
1.36 |
61 |
46 |
102.2 |
-0.40 |
6.4e-04 |
AC006547.14 AC074117.10 ACBD4 ALOXE3 C14orf39 C16orf93 C17orf58 CD164 CEP85 CPEB4 CRTAP CTC-228N24.3 CTD-2020K17.4 CUX2 DCST2 DEF6 DOC2A EFCAB13 EFEMP2 FAM133B GATAD1 GNA12 GPN3 HINT1 HIVEP3 HSD3B7 KRIT1 LIN7C LOC595101 NFKBIA NOSTRIN NUDT3 PACSIN1 PARP12 PEX1 PGC PHC2 PPP4C PPTC7 RAB5B REST RIN3 RMND1 RP11-231C14.4 RP11-617D20.1 RP11-981P6.1 RPN1 RSBN1L-AS1 SBNO1 SEPT2 SLC22A5 TBX6 TCTA TEAD3 TRIM73 TRIM8 UBA7 UPF3A VPS29 ZNF500 ZRANB1 |
Arm fat percentage (left) |
1.24 |
32 |
27 |
60.0 |
0.13 |
4.3e-01 |
ABO C16orf93 C17orf58 CENPO DOC2A HSD3B7 IQCH LIN7C LINC00674 LOC595101 LRRC25 LRRC37A16P MAP2K2 MAP2K5 MAST3 NOB1 PPARG PPP4C RHOA-IT1 RP11-138A9.1 RP11-231C14.4 RP11-981P6.1 RP5-1115A15.1 SIDT2 SMAD3 TBX6 TCTA TEAD3 TRIM73 UBA7 USP3 WBP2 |
Handedness (chirality/laterality): Left-handed |
0.96 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
PLEKHM1 |
Mood swings |
1.06 |
5 |
3 |
6.7 |
-0.05 |
9.4e-01 |
ARL17B EP300 L3MBTL2 PLEKHM1 UBA7 |
Long-standing illness, disability or infirmity |
1.30 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
IQCH ZNF652 |
Ever had bowel cancer screening |
1.25 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SIK2 |
Diabetes diagnosed by doctor |
1.36 |
8 |
6 |
13.3 |
-0.08 |
8.1e-01 |
EIF2S2P3 HHEX JAZF1 KIF11 RP11-138A9.1 TCTA UBA7 ZFP36L2 |
Mouth/teeth dental problems: Mouth ulcers |
1.40 |
9 |
6 |
13.3 |
-0.04 |
9.3e-01 |
ARNT CTSS FYCO1 GOLPH3L IRF5 IRF8 PLEKHM1 PPP5C SMC4 |
Medication for cholesterol |
1.13 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
RP11-138A9.1 SH2B3 |
Asthma (self-reported) |
4.34 |
60 |
50 |
111.1 |
0.82 |
1.1e-20 |
AC074212.6 AC093642.3 AC114730.11 AC114730.7 AHI1 B4GALT3 BACH2 C11orf10 CD247 CLEC16A CTD-3203P2.1 D2HGDH DEF6 DEXI DMWD EIF2S2P3 FADS1 FADS2 FPR3 GLDC GMEB2 GPR182 GSDMB HHEX IL18RAP IL1R2 IL1RL1 IL4R IL7R IQCH JMJD5 KIAA1109 KIAA1432 KIF11 KIF3A LRRC32 MED24 NDFIP1 NRROS ORMDL3 POLI PPP1R1B RAB5B RP11-396B14.2 RP11-876N24.4 RP5-1115A15.1 SIK2 SIX5 SLC22A5 SLC25A46 SLC9A2 SMAD3 SPPL3 STAT6 TBX6 THRA TSLP UBAC2 WDR36 ZNF652 |
Forced expiratory volume in 1-second (FEV1), predicted percentage |
1.10 |
10 |
5 |
11.1 |
0.04 |
9.1e-01 |
ARL17B CTSS FBXO38 GSDMB MRPS21 NOB1 ORMDL3 PLEKHM1 PPP1R1B RIN3 |
Whole body water mass |
1.39 |
66 |
52 |
115.6 |
-0.44 |
8.0e-05 |
AC074117.10 ACBD4 ADAM1A ALOXE3 C14orf39 C17orf58 C6orf81 CD164 CEP85 CTC-228N24.3 CTD-2020K17.4 CUX2 DCST2 DEF6 DOC2A EFEMP2 FAM133B GATAD1 GNA12 GPN3 HINT1 HIVEP3 HSD3B7 KRIT1 LIN7C LOC595101 MAX NFATC3 NFKBIA NOSTRIN NUDT3 PACSIN1 PAPD7 PARP12 PEX1 PGC PHC2 PPP4C PPTC7 PSMC3 RAB5B REST RIN3 RMND1 RNF185 RP11-231C14.4 RP11-617D20.1 RSBN1L-AS1 SBNO1 SEC16A SEPT2 SH2B3 SLC22A5 STAT6 TBX6 TCTA TEAD3 TRIM8 UBA7 UBE2Z UPF3A VPS29 WAC-AS1 ZNF414 ZNF500 ZRANB1 |
Leg predicted mass (right) |
1.36 |
59 |
46 |
102.2 |
-0.42 |
4.4e-04 |
AC006547.14 AC074117.10 ACBD4 ALOXE3 C14orf39 C16orf93 C17orf58 CD164 CEP85 CPEB4 CTC-228N24.3 CTD-2020K17.4 CUX2 DCST2 DEF6 DOC2A EFCAB13 EFEMP2 FAM133B GATAD1 GNA12 GPN3 HINT1 HIVEP3 HSD3B7 KRIT1 LIN7C LOC595101 NFKBIA NOSTRIN NUDT3 PACSIN1 PARP12 PEX1 PGC PHC2 PPP4C PPTC7 RAB5B REST RIN3 RMND1 RP11-231C14.4 RP11-617D20.1 RPN1 RSBN1L-AS1 SBNO1 SEPT2 SLC22A5 TBX6 TCTA TEAD3 TRIM73 TRIM8 UBA7 UPF3A VPS29 ZNF500 ZRANB1 |
Arm fat mass (left) |
1.30 |
40 |
26 |
57.8 |
-0.10 |
5.3e-01 |
C16orf93 C17orf58 CD164 CENPO DOC2A GPN3 HINT1 HSD3B7 IQCH LIN7C LINC00674 LOC595101 LRRC25 LRRC37A16P MAP2K2 MAP2K5 MAST3 NOB1 NUDT3 OAS3 PACSIN1 PHC2 PPP4C PPTC7 RAB5B RP11-231C14.4 RP11-981P6.1 RP5-1115A15.1 RSBN1L-AS1 SIDT2 SMAD3 TBX6 TCTA TEAD3 TRIM73 TRIM8 UBA7 VPS29 WBP2 ZNHIT3 |
Number of self-reported non-cancer illnesses |
1.55 |
8 |
4 |
8.9 |
0.83 |
5.7e-03 |
GSDMB IL1RL1 IQCH LRRC32 ORMDL3 RP11-396B14.2 SH2B3 ZNF652 |
Average weekly champagne plus white wine intake |
1.11 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
C11orf10 |
Miserableness |
1.11 |
5 |
3 |
6.7 |
-0.63 |
2.5e-01 |
AMT ARL17B PLEKHM1 RP5-1115A15.1 UBA7 |
Guilty feelings |
1.12 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
PLEKHM1 TCEA3 |
Tinnitus: Yes, now most or all of the time |
1.03 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
PNPO |
Medication: Blood pressure |
1.21 |
7 |
3 |
6.7 |
0.87 |
1.1e-02 |
ARL17B KAT5 MYNN PLEKHM1 RP11-138A9.1 SH2B3 SLC22A5 |
Pain type(s) experienced in last month: Hip pain |
1.05 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
NOV |
High cholesterol (Self-reported) |
1.47 |
9 |
8 |
17.8 |
-0.21 |
5.8e-01 |
ABO CARM1 FAM46B LPL SIDT2 TOMM40 TSEN2 WBP2 ZNF259 |
Medication: Bendroflumethiazide |
1.14 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
HSD3B7 SLC22A5 |
Medication: Paracetamol |
1.01 |
4 |
3 |
6.7 |
-0.97 |
2.6e-02 |
AMT ARL17B PLEKHM1 STAT6 |
Medication: Atorvastatin |
1.23 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
TOMM40 ZNF259 |
Ever smoked |
1.06 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
PHC2 |
Basal metabolic rate |
1.39 |
66 |
49 |
108.9 |
-0.39 |
7.6e-04 |
AC074117.10 ACBD4 ALOXE3 C14orf39 C16orf93 C17orf58 C6orf81 CD164 CEP85 CTC-228N24.3 CTD-2020K17.4 CUX2 DCST2 DEF6 DESI1 DOC2A EFEMP2 FAM133B GATAD1 GNA12 GPN3 HINT1 HIVEP3 HSD3B7 IQCH KRIT1 LIN7C LINC00674 LOC595101 LRRC37A16P MAX NFATC3 NFKBIA NOSTRIN NUDT3 PACSIN1 PAPD7 PARP12 PEX1 PGC PHC2 PPP4C PPTC7 RAB5B REST RIN3 RMND1 RP11-231C14.4 RP11-617D20.1 RSBN1L-AS1 SBNO1 SEC16A SEPT2 SH2B3 SLC22A5 TBX6 TCTA TEAD3 TRIM73 TRIM8 UBA7 UPF3A VPS29 ZNF414 ZNF500 ZRANB1 |
Leg fat percentage (left) |
1.30 |
38 |
25 |
55.6 |
0.32 |
4.0e-02 |
AKAP11 ATP9A C16orf93 C17orf107 C17orf58 CENPO CTC-228N24.3 DLEU1 DOC2A GMEB2 GPN3 HSD3B7 IQCH LIN7C LINC00674 LOC595101 LRRC25 LRRC37A16P MAP2K2 MAP2K5 MAST3 NOB1 PPARG PPP4C PPTC7 PSMC3 RIN3 RP11-231C14.4 RP11-981P6.1 RP5-1115A15.1 SIDT2 SMAD3 TBX6 TCTA TEAD3 TFPI TRIM73 UBA7 |
Arm fat-free mass (left) |
1.41 |
59 |
47 |
104.4 |
-0.44 |
1.6e-04 |
AC074117.10 ACBD4 ADAM1A ALOXE3 C14orf39 C17orf58 C6orf81 CD164 CTD-2020K17.4 CUX2 DEF6 DOC2A EFEMP2 FAM133B GATAD1 GNA12 GPN3 HINT1 HSD3B7 KRIT1 LIN7C LINC00674 LOC595101 MAX NFATC3 NFKBIA NOSTRIN NUDT3 PACSIN1 PAPD7 PARP12 PEX1 PGC PHC2 PPP4C PPTC7 PSMB7 RAB5B RAPGEF1 REST RIN3 RNF185 RP11-231C14.4 RSBN1L-AS1 SBNO1 SEC16A SEPT2 SH2B3 SLC22A5 TBX6 TCTA TEAD3 TRIM8 UBA7 UPF3A VPS29 ZNF414 ZNF500 ZRANB1 |
Number of operations (self-reported) |
1.16 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
MYNN PSMB7 |
Average weekly beer plus cider intake |
1.16 |
5 |
1 |
2.2 |
0.98 |
9.1e-04 |
HIP1 MDH2 POR TCTA UBA7 |
Irritability |
1.12 |
4 |
1 |
2.2 |
-0.73 |
1.6e-01 |
C11orf10 L3MBTL2 P4HTM PLEKHM1 |
Fractured/broken bones in last 5 years |
1.16 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
C17orf58 |
Diastolic blood pressure, automated reading |
1.34 |
27 |
18 |
40.0 |
0.51 |
2.6e-03 |
ABO AC002310.12 AC010883.5 ARRB2 C16orf93 CIAO1 CLIC4 CPEB4 CSTA GPN3 HSD3B7 ITPRIPL1 MAPKAPK5-AS1 MAST3 MED19 OIP5-AS1 PELP1 PPTC7 RP5-1115A15.1 SBNO1 SENP7 SH2B3 TMEM116 TRIM73 UBA7 VPS29 ZNF652 |
Myopia |
1.06 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
STAT6 |
Vascular/heart problems diagnosed by doctor |
1.30 |
21 |
7 |
15.6 |
-0.75 |
9.3e-05 |
AC006547.14 ACTR1B ADRB2 ARL17B FLJ13197 HSD3B7 IQCH MAPKAPK5-AS1 OIP5-AS1 PSMC3 RP11-617D20.1 RP5-1115A15.1 SH2B3 SIK2 SLC22A5 TMEM116 TP53INP1 TRMT61A TSPY26P UBE2Z ZNF652 |
Cholesterol lowering medication |
1.43 |
7 |
4 |
8.9 |
-0.32 |
4.8e-01 |
ABO CARM1 FAM46B LPL RP11-138A9.1 TOMM40 ZNF259 |
Pain experienced in last month |
1.15 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
KCTD10 RAB5B STAT6 |
Heart attack/myocardial infarction (self-reported) |
1.15 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
ZFP36L2 ZNF652 |
Deep venous thrombosis (DVT) (self-reported) |
1.75 |
1 |
1 |
2.2 |
-0.98 |
2.1e-02 |
ABO |
Pack years of smoking |
0.97 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
P4HTM |
Impedance of whole body |
1.30 |
61 |
49 |
108.9 |
0.30 |
1.5e-02 |
ABO AC006547.14 AC074117.10 AC103965.1 ACBD4 AMT ARL17B ARNT ATP6V0D1 C6orf164 CNP CTC-228N24.3 CTD-2020K17.4 CTSS DCST2 DOC2A EFEMP2 EIF4ENIF1 EP300 GMIP HEMK1 HIGD1A HINT1 HSD3B7 ITIH4-AS1 JAZF1 L3MBTL2 LIN7C LOC595101 LRRC25 NDFIP1 NFATC3 NUDT3 P4HTM PACSIN1 PGC PHC2 PISD PLA2G15 PLEKHM1 PPP4C PSMB7 RAB5B RHOA-IT1 RIN3 RMI1 RNF185 RNF215 RP11-231C14.4 SEMA3B-AS1 TBX6 TEAD3 TNIP2 TRIM73 TRIM8 TSPAN3 UBA7 UPF3A VPS29 ZFP36L2 ZNF652 |
Leg fat mass (left) |
1.31 |
41 |
32 |
71.1 |
-0.05 |
7.3e-01 |
AKAP11 C16orf93 C17orf58 CD164 CENPO DOC2A EFEMP2 GPN3 HSD3B7 IQCH LIN7C LINC00674 LOC595101 LRRC25 LRRC37A16P MAP2K2 MAP2K5 MAST3 MRPS21 NOB1 NUDT3 PACSIN1 PHC2 PPP4C PPTC7 RAB5B RP11-231C14.4 RP11-981P6.1 RP5-1115A15.1 RSBN1L-AS1 SIDT2 SMAD3 TBX6 TCTA TEAD3 TFPI TNFRSF14 TRIM73 TRIM8 UBA7 VPS29 |
Arm predicted mass (left) |
1.40 |
59 |
44 |
97.8 |
-0.42 |
3.3e-04 |
ABO AC074117.10 ACBD4 ADAM1A ALOXE3 C14orf39 C17orf58 C6orf81 CD164 CTD-2020K17.4 CUX2 DEF6 DOC2A EFEMP2 FAM133B GATAD1 GNA12 GPN3 HINT1 HSD3B7 KRIT1 LIN7C LINC00674 LOC595101 MAX NFATC3 NFKBIA NOSTRIN NUDT3 PACSIN1 PAPD7 PARP12 PEX1 PGC PHC2 PPP4C PPTC7 PSMB7 RAB5B REST RIN3 RNF185 RP11-231C14.4 RSBN1L-AS1 SBNO1 SEC16A SEPT2 SH2B3 SLC22A5 TBX6 TCTA TEAD3 TRIM8 UBA7 UPF3A VPS29 ZNF414 ZNF500 ZRANB1 |